Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke

Phase 2 Completed 50 enrolled Castillo, José, M.D.

RandomizedParallel-groupDouble-blindTreatment

Summary

Administration of CBG000592 (riboflavin/vitamin B2) in patients with acute ischemic stroke to know if it causes a reduction of glutamate-mediated excitotoxicity.

Timeline

Start: 2015-03
Primary completion: 2015-12
Completion: 2015-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Riboflavin	Other / unclassified	20 mg	Intravenous

Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke

Summary

Timeline

Drugs

Indications